1. Home
  2. OTLY vs ABEO Comparison

OTLY vs ABEO Comparison

Compare OTLY & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oatly Group AB

OTLY

Oatly Group AB

HOLD

Current Price

$13.51

Market Cap

320.7M

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.52

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTLY
ABEO
Founded
1994
1974
Country
Sweden
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
320.7M
280.2M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
OTLY
ABEO
Price
$13.51
$5.52
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$14.50
$20.00
AVG Volume (30 Days)
72.4K
1.2M
Earning Date
04-29-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.16
EPS
N/A
1.01
Revenue
N/A
$2,998,000.00
Revenue This Year
$7.91
$1,024.31
Revenue Next Year
$5.50
$145.42
P/E Ratio
N/A
$5.46
Revenue Growth
N/A
258.18
52 Week Low
$8.80
$4.00
52 Week High
$18.84
$7.54

Technical Indicators

Market Signals
Indicator
OTLY
ABEO
Relative Strength Index (RSI) 74.72 68.30
Support Level $13.36 $5.24
Resistance Level $18.41 $5.62
Average True Range (ATR) 0.65 0.23
MACD 0.35 0.11
Stochastic Oscillator 88.58 98.39

Price Performance

Historical Comparison
OTLY
ABEO

About OTLY Oatly Group AB

Oatly Group AB produces and distributes oat-based food and beverage products. Its offerings include milk, cooking creams, spreads, and yogurts. The company's products are sold through retail stores, coffee shops, and restaurants across multiple countries. It generates revenue from sales of oatmilk and other oat-based products. The company's geographical segments include Europe & International, North America and Greater China. The Europe & International segment is its maximum revenue-producing segment, followed by the North America and Greater China segments.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: